Allarity Gets Japanese Patent For Stenoparib DRP Companion Diagnostic; Protection Through 2039

Allarity Therapeutics (ALLR) received a Japanese patent covering its stenoparib-specific DRP companion diagnostic, providing protection through 2039. The patent covers methods for predicting treatment benefit and selecting patients likely to respond to stenoparib.